07
July 2020
Agenda 3 de Junio
17:30 Panamá / 16:30 Centro América
Mesa Redonda
Cuantificación de anticuerpos anti-Spike del SARS-CoV-2
17:30 - 19:30 Panamá
16:30 - 18:30 Centro América
Bienvenida e Introducción
Dra. Kharis Rebollón
La respuesta de Roche a la pandemia COVID-19
17:40 -17:45
María Paula De León
Medición cuantitativa de anticuerpos anti-Spike: La próxima frontera en las pruebas de anticuerpos contra el SARS-CoV-2
17:45 -18:00
Dra. Soledad Reyes
Vacunación y estudios de seroprevalencia: ¿Qué papel pueden desempeñar las pruebas de anticuerpos contra el SARS-CoV-2?
18:00 - 18:30
Dra. Elizabeth Vinelli
El valor de la cuantificación de anticuerpos anti-Spike al SARS-CoV-2 en la terapia con plasma convaleciente
18:30 - 19:00
Cierre
2nd Webinar
Lorem ipsum 08 July 2020
15:00 - 16:15 CET
Welcome and introduction
Prof. James Januzzi
Is a member of the Massachusetts General Hospital Cardiology Division. He is the Hutter Family Professor of Medicine at Harvard Medical School and is on faculty at the Harvard Clinical Research Institute
13:30-13:45
Dr. Raphael Twerenbold
Is an interventional cardiologist and senior physician at the Clinic for Cardiology at the University Hospital Basel
13:30-13:45
Prof. Alexandre Mebazaa
Is Professor of Anaesthesiology and Critical Care Medicine at the Hôpital Lariboisière, University Paris 7, France
13:30-13:45
Dr. Zhou Ning
Associate Professor, Division of Cardiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
13:30-13:45
Q& session
3rd Webinar
Lorem ipsum 14 July 2020
15:00 - 16:15 CET
Welcome and introduction
W. Conrad Liles
MD, PhD, University of Washington, Seattle, US
13:30-13:45
Tobias Weinberger
MD, Ludwig Maximilian University of Munich, Munich, Germany
13:30-13:45
Q& session
4th Webinar
Lorem ipsum 16 July 2020
15:00 - 16:15 CET
Welcome and introduction
Prof. Anna Kajdy
Head of Obstetrics Department, St. Sophie's Obstetrics and Gynecology Hospital, Warsaw, Poland
13:30-13:45
Prof. Liona Poon
Clinical Professor, Obstetrics, CUHK, Hong Kong
13:30-13:45
Q& session
#pruebasdediagnostico
Temas a tratar en la mesa redonda:
- La respuesta de Roche Dignostics ante la pandemia de la COVID-19
- Generalidades y uso previsto de las pruebas cuantitativas de anticuerpos spike.
- El rol de anticuerpos anti-Spike del SARS-CoV-2 en evaluación de vacunas y estudios de seroprevalencia
- El valor de la cuantificación de anticuerpos anti-Spike al SARS-CoV-2 en la terapia con plasma convalesciente
**Evento dirigido a profesionales relacionados a la industria de la salud. Gratuito.
#Covid19Webinar
08 July 2020 Webinar
Coagulopathy in COVID-19: Which challenges do we face in the area of Coagulation.
SARS-CoV-2 has caused a pandemic with high mortality and is commonly complicated with coagulopathy, which is one of the most significant poor prognostic features of the disease.
Systemic coagulation activation and thrombotic complications, such as venous thromboembolism, emerged as an important consideration in the management of patients.
Experts around the globe are heavily seeking to understand the pathophysiological aspects and to provide guidance in therapy.
In this webinar, which will focus entirely on topics related to the field of Coagulation,
#Covid19Webinar
14 July 2020 Webinar
Coagulopathy in COVID-19: Which challenges do we face in the area of Coagulation.
SARS-CoV-2 has caused a pandemic with high mortality and is commonly complicated with coagulopathy, which is one of the most significant poor prognostic features of the disease.
Systemic coagulation activation and thrombotic complications, such as venous thromboembolism, emerged as an important consideration in the management of patients.
Experts around the globe are heavily seeking to understand the pathophysiological aspects and to provide guidance in therapy.
In this webinar, which will focus entirely on topics related to the field of Coagulation,
SARS-CoV-2 has caused a pandemic with high mortality and is commonly complicated with coagulopathy, which is one of the most significant poor prognostic features of the disease.
SARS-CoV-2 has caused a pandemic with high mortality and is commonly complicated with coagulopathy, which is one of the most significant poor prognostic features of the disease.
#Covid19Webinar
16 July 2020 Webinar
Coagulopathy in COVID-19: Which challenges do we face in the area of Coagulation.
SARS-CoV-2 has caused a pandemic with high mortality and is commonly complicated with coagulopathy, which is one of the most significant poor prognostic features of the disease.
Systemic coagulation activation and thrombotic complications, such as venous thromboembolism, emerged as an important consideration in the management of patients.
Experts around the globe are heavily seeking to understand the pathophysiological aspects and to provide guidance in therapy.
In this webinar, which will focus entirely on topics related to the field of Coagulation,
Panelistas invitados
En este conversatorio, nuestros panelistas discutirán detalles importantes sobre la cuantificación de anticuerpos específicos anti-Spike del SARS-CoV-2 en el contexto de vacunas, seroprevalencia y uso en plasma convalesciente.
Dra. Soledad Reyes
Dra. Elizabeth Vinelli
Regístrese aquí
Favor complete el siguiente formulario para separar cupo en el evento.
(*) Mandatorio
(*) Mandatorio
